🎙️ JLS Podcast: Hosted by William Leonard Pickard

🚀 About Carl Hart
Carl Hart is a neuroscientist, professor, and outspoken advocate for evidence-based drug policy and human autonomy. A former Air Force serviceman who rose to become a leading researcher at Columbia University, Hart has dedicated his career to challenging misinformation, dismantling stigma, and defending the dignity and rights of individuals who use psychoactive substances.

🧠 From Miami to Neuroscience: A Life Shaped by Systems
Hart’s journey—from growing up in Miami to joining the Air Force and eventually entering the world of neuroscience—reveals how structural forces shape opportunity. His work insists that understanding drugs requires understanding the brain, but also understanding society—how narratives, politics, and inequality influence the way we interpret both. 

⚖️ Debunking the “Brain Disease” Model of Addiction
Hart directly challenges the dominant claim that addiction is a chronic brain disease. He argues that this narrative is largely political, not scientific, and can be harmful—encouraging fatalism while limiting humane and effective treatment approaches. Instead, he emphasizes data showing that most people recover and that addiction cannot be diagnosed from brain scans alone. 

🌿 Responsible Use, Bodily Autonomy, and Honesty
Through his book Drug Use for Grown-Ups, Hart publicly acknowledges his own responsible use of illicit substances—an act he frames not as radical, but as simple honesty. His goal is to normalize the reality that many adults use psychoactive substances responsibly, just as they engage in other forms of leisure, and to reclaim the right to bodily autonomy. 

🔬 What the Science Actually Shows
Across major research institutions, Hart explains, substances like heroin, cocaine, methamphetamine, and cannabis are administered to human participants in controlled studies every day. The resulting data reveal that the predominant effects are often positive—improvements in mood, cognition, and alertness—while harms are typically linked to social context, adulterated supply, or preexisting conditions, not the drugs themselves. 

🛑 Stigma, Policy, and the Real Sources of Harm
Hart emphasizes that many harms associated with drugs arise not from chemistry but from prohibition: contaminated supply chains, criminalization, and lack of social support. He points to real-world harm reduction efforts—like community drug-checking initiatives—as compassionate, evidence-based solutions that save lives. 

🌍 Freedom, Civil Liberties, and a Global Perspective
Through travel and reflection, Hart frames drug policy as part of a broader conversation about human rights and civil liberties. He highlights places like Portugal—where decriminalization and public health approaches allow individuals to exist without fear—as glimpses of what a freer and more humane future could look like.

😂 Humor, Humanity, and the Absurdity of the Drug War
From research participants expressing pride in government-grown cannabis to border agents suspicious of his academic credentials, Hart shares stories that reveal the strange contradictions embedded in modern drug policy—where stigma, fear, and misinformation often collide with reality.

💬 Empathy as a Superpower
If given a superpower, Hart says he would give people the ability to feel each other’s suffering as their own. For him, empathy—not punishment—is the foundation of a just and compassionate society.

🎶 The Soundtrack of Liberation
If his life had a soundtrack, Hart says it would be Nina Simone—songs of liberation, dignity, and the ongoing journey toward freedom.

🏆 Final Takeaways
A bold, clear-eyed conversation that reframes drugs not as moral failings or medical myths—but as human experiences shaped by context, culture, and policy. Carl Hart invites us to question dominant narrative

🎙️ JLS Podcast: Hosted by William Leonard Pickard

🚀 About Tom Feegel
Tom Feegel is the co-founder (with Tali Eisenberg) of BEOND Ibogaine Clinic in Cancún, a medically rigorous program at the forefront of ibogaine-based treatment. Unlike lab-based research or policy debates, Feegel works directly with patients—building real-world protocols for safety, ethics, and long-term healing.

🫀 Safety, Medicine, and Ethical Care
Feegel details BEOND’s intensive medical framework, including physician-led screening, cardiac monitoring, repeat diagnostics, and strict eligibility standards. The conversation offers a rare look into how ibogaine can be administered responsibly, emphasizing transparency, patient education, and risk mitigation.

🧠 Ibogaine, Neuroplasticity, and Cognitive Renewal
Moving beyond addiction alone, Pickard and Feegel explore ibogaine’s potential to enhance cognition, restore neural pathways, and support executive function. Drawing on clinical observation and emerging research, they discuss ibogaine’s unusually long window of neuroplasticity and its implications for performance, learning, and personal growth.

🔁 Addiction, Relapse, and the Power of Integration
Feegel speaks candidly about relapse, aftercare, and why community support is essential. He explains how ibogaine often restores a sense of choice—helping patients re-engage with life, relationships, and responsibility—while emphasizing that healing extends beyond the individual to families and social systems.

🏛️ From Clinics to Congress
In a bold initiative, BEOND has offered treatment to elected officials—not to lobby, but to heal. Feegel reflects on how firsthand experience can shift perspectives on trauma, addiction, and policy, contributing to broader cultural and regulatory change.

🌿 Meaning, Nature, and the Human Spirit
Interwoven with clinical rigor are moments of humor and humanity—stories of insight, connection with nature, and the subtle wisdom that emerges during integration. Together, they explore how ibogaine bridges medicine, meaning, and spiritual inquiry.

🏆 Final Takeaways
A grounded, deeply human conversation on ibogaine as both medicine and catalyst—examining safety, science, compassion, and the conditions required for true, lasting transformation.

✨ Support this work and unlock exclusive interviews with leaders in healing, neuroscience, and culture on Patreon:
https://www.patreon.com/c/thelastalchemist

🔗 Subscribe for more conversations at the intersection of psychedelics, medicine, ethics, and transformation.

🎙️ JLS Podcast

Hosted by William Leonard Pickard

🚀 About Norman Ohler
International bestselling author of Blitzed and Tripped, Norman Ohler is a historian and cultural investigator whose work exposes the hidden role of drugs in shaping 20th-century war, fascism, and modern consciousness. His research has reframed how we understand the Third Reich, LSD’s origins, and the pharmacological forces behind power and control.

🧠 Drugs, War, and the Third Reich
Ohler unpacks his groundbreaking archival discoveries revealing the widespread use of methamphetamine (Pervitin) within the Nazi military—and Adolf Hitler’s personal dependence on opioids and other substances. The conversation explores how stimulants, sedatives, and drug control fueled aggression, obedience, and catastrophic decision-making at the highest levels of the regime.

🧪 LSD, MKUltra, and the Dark Origins of Psychedelic Research
Tracing LSD’s early history, Ohler reveals its links to Nazi experimentation, post-war U.S. intelligence programs, and the pursuit of a so-called “truth drug.” Pickard and Ohler examine the ethical failures of MKUltra and the lasting implications for neuroscience, policy, and psychedelic medicine today.

🌈 Psychedelics, Trauma, and Healing
Moving beyond the shadows of war, the discussion turns toward healing—exploring LSD microdosing, ibogaine, and their potential roles in addressing trauma, addiction, and neurodegenerative disease. Ohler shares the deeply personal story of his mother’s Alzheimer’s and how psychedelics opened moments of clarity, presence, and connection.

🌍 From Nation States to Planetary Consciousness
Ohler reflects on the future of humanity in an age of AI, collapsing hierarchies, and unresolved collective trauma. He argues for the necessity of ritual, community-based psychedelic access, and a cultural shift away from extractive systems toward simplicity, compassion, and planetary responsibility.

📚 Stone Sapiens & the Drug History of Humanity
Looking ahead, Ohler introduces his forthcoming work Stone Sapiens—a sweeping re-examination of human history through the lens of psychoactive substances, from early hominids to modern civilization, revealing drugs as inseparable from culture, religion, power, and control.

🏆 Final Takeaways
A wide-ranging and unflinching conversation on drugs and domination, psychedelics and healing, fascism and freedom—offering rare historical insight into how chemistry has shaped human behavior, and how consciousness may yet shape our future.

✨ Support this work and unlock exclusive interviews with pioneers in psychedelic history, science, and culture on Patreon:
https://www.patreon.com/c/thelastalchemist

🔗 Subscribe for more conversations at the intersection of psychedelics, history, power, and transformation.

🚀 Background on David Bronner
Cosmic CEO of Dr. Bronner’s, activist, burner, philanthropist, and longtime force in drug policy reform.

🌈 Psychedelic Origins
Bronner reflects on the transformative psychedelic initiations that shaped his life—from early LSD/MDMA experiences in Amsterdam to a deep Bwiti iboga ceremony in Gabon. These journeys ignited his lifelong commitment to service, compassion, and spiritual activism.

🏛️ Business With Purpose
Pickard and Bronner explore how Dr. Bronner’s scaled into a global company while staying rooted in ethical values. Bronner shares the vision behind The Purpose Pledge, a new framework promoting living wages, regenerative agriculture, fair labor, and mission-aligned capital—helping companies remain ethically aligned as they grow.

🌿 Future of Psychedelic Access
The conversation looks at where psychedelic policy is heading: regulated therapeutic programs, competent facilitators, insurance coverage—and thriving, responsible, self-regulating entheogenic communities modeled after Indigenous traditions.

🚨 Frontlines of Activism
Bronner recounts his bold protests at DEA headquarters—die-ins, washable painted messages, and civil disobedience supporting terminal patients seeking psilocybin under Right to Try.

🌱 Regeneration & Connection
They explore regenerative organic agriculture, ethical sourcing across Palestinian and Israeli farming communities, and the deeper need to reconnect land, labor, and spirit.

🔍 What’s Next
Together, Pickard and Bronner consider the future of psychedelic culture—scientific breakthroughs, cultural shifts, community-based healing, and the role of ethical business in shaping a more compassionate world.

🏆 Final Takeaways
A dialogue rich with psychedelic insight, activism, spirituality, and cultural transformation—offering a grounded yet visionary look at what lies ahead.

✨ Support this work and unlock exclusive interviews with pioneers like Hamilton Morris, William Leonard Pickard, and other leaders in psychedelic science and culture on Patreon:
https://www.patreon.com/c/thelastalchemist

🔗 Stay tuned for more from the frontlines of psychedelic research, culture, and transformation.

🎙️ JLS Fund Podcast: William Leonard Pickard in conversation with Hamilton Morris

🚀 Background on Hamilton Morris: Journalist, documentarian, and creator of the Hamilton’s Pharmacopeia series, known for exploring the cultural, chemical, and human dimensions of psychedelics.

🧠 Inside Hamilton’s Pharmacopeia Morris shares the vision behind his groundbreaking series, the ethical dilemmas faced in filming, and the delicate balance between storytelling and scientific responsibility. His work highlights the voices of chemists, users, and communities often overlooked in mainstream narratives.

💊 Big Pharma & Medicalization The discussion explores the role of pharmaceutical companies in psychedelic research, the misconceptions surrounding medicalization, and the broader implications for accessibility and equity in treatment.

🚨 Behind the Scenes at the DEA Pickard and Morris reflect on Morris’s rare visit to the DEA headquarters, unpacking insights about policy, enforcement, and the contradictions inherent in the regulation of psychedelics.

🌿 Community & Collaboration Beyond the science and politics, the conversation emphasizes the importance of community in psychedelic culture—how collaboration, shared knowledge, and personal experience continue to shape the future of the field.

🔍 What’s Next The two visionaries speculate on the trajectory of psychedelic research, from evolving scientific studies to the cultural shifts redefining how society views these substances.

🏆 Final Takeaways This dialogue offers a rare blend of personal reflection and cultural critique, spotlighting both the promise and the pitfalls of a rapidly changing psychedelic landscape.

✨ Support this work and unlock exclusive interviews with pioneers like Hamilton Morris, William Leonard Pickard, and other leaders in psychedelic science and culture on Patreon:

  / thelastalchemist 

🔗 Stay tuned for more updates from the frontlines of psychedelic research, culture, and storytelling

In this interview, we speak with Bryan Hubbard — legal expert, policy leader, and Executive Director of the American Ibogaine Initiative, as well as CEO of Americans for Ibogaine, a nonprofit advancing research into ibogaine’s neurorestorative potential.

From securing $50 million in state-backed funding for ibogaine research in Texas to shaping national drug policy and advocating for underserved communities, Hubbard brings vision, strategy, and heart to the frontier of psychedelic medicine. His work bridges law, science, and public trust while opening new pathways for addiction treatment, PTSD recovery, and neurorestoration.

Tune in to explore the cutting edge of psychedelic advocacy, drug policy, and transformative healing.

Support this work and enjoy early access to exclusive interviews with biotech CEOs, ethicists, and pioneers in AI-driven drug discovery, before they’re released to the public, on Patreon:

https://www.patreon.com/c/thelastalchemist

In this inaugural interview for the JLS Podcast, we speak with Jonathan Sporn — CEO of Gilgamesh Pharmaceuticals, Harvard MD, and former Pfizer researcher. From partnering with Columbia University chemists to designing novel psychedelic-inspired molecules to leading one of the largest biotech deals in history with AbbVie, Sporn brings vision, innovation, and scientific rigor to the frontier of psychedelic medicine. Tune in to explore the cutting edge of drug development, neuroplasticity, and transformative therapies.

Support this work and enjoy early access to exclusive interviews with biotech CEOs, ethicists, and pioneers in AI-driven drug discovery, before they’re released to the public, on Patreon:

https://www.patreon.com/c/thelastalchemist

In this inaugural interview, we speak with Bryan Hubbard — legal strategist, psychedelic policy architect, and advocate for ibogaine as a tool for healing addiction, trauma, and systemic neglect.

From leading multimillion-dollar state initiatives to reshaping the future of drug policy, Hubbard brings vision, grit, and heart to the frontier of psychedelic medicine.

Tune in to explore the edge of law, neuroscience, and transformation.

Support this work and enjoy early access to exclusive interviews with biotech CEOs, ethicists, and pioneers in AI-driven drug discovery, before they’re released to the public, on Patreon:

https://www.patreon.com/c/thelastalchemist